Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2010
The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: a randomized, double-blind, placebo-controlled studyEndre Pal, Ferenc Nagy, Zsuzsanna Aschermann, et al.
Ideggyogyaszati Szemle|November 9, 2007
Persistent akinetic-rigid side effects of neuroleptics may indicate Wilson's diseaseZsuzsanna Aschermann, Ferenc Szalay, Erzsébet Schmidt, et al.
Psychiatria Hungarica : a Magyar Pszichiatriai Tarsasag Tudomanyos Folyoirata|July 22, 2014
[Treatment of tardive syndromes]Krisztina Horváth, Zsuzsanna Aschermann, Sámuel Komoly, et al.
Ideggyogyaszati Szemle|February 21, 2019
[Selection of the optimal device-aided therapy in Parkinson's disease]Norbert Kovács, Zsuzsanna Aschermann, Annamária Juhász, et al.
Ideggyogyaszati Szemle|June 3, 2026
[The current status of pump therapy options for advanced Parkinson's disease in Hungary]Norbert Kovács, Mirtill Rohonczi, Annamária Juhász, et al.
Ideggyogyaszati Szemle|April 1, 2008
[Special aspects of patient care after implantation of deep-brain-stimulator]Norbert Kovács, István Balás, József Janszky, et al.
Ideggyogyaszati Szemle|December 14, 2019
[The applicability of 123I-FP-CIT SPECT dopamine transporter imaging in clinical practice]Gábor Perlaki, Sarolta Szekeres, József Janszky, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 2018
Are the MDS-UPDRS-Based Composite Scores Clinically Applicable?Attila Makkos, Márton Kovács, Zsuzsanna Aschermann, et al.
Ideggyogyaszati Szemle|December 17, 2014
[The impact of levodopa-carbidopa intestinal gel on health-related quality of life in Parkinson's disease]Norbert Kovács, Zsuzsanna Aschermann, Péter Ács, et al.
Ideggyogyaszati Szemle|May 8, 2018
[Recommendation for treatment options in advanced Parkinson's disease]Zsuzsanna Aschermann, György Dibó, Péter Klivényi, et al.
Pageof 4